A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Pfizer
Brigham and Women's Hospital
Brigham and Women's Hospital
University of Waterloo
University of Massachusetts, Worcester
University of Massachusetts, Worcester
Tulane University
Merck Sharp & Dohme LLC
Columbia University
Duke University
William Paterson University of New Jersey
Menarini International Operations Luxembourg SA
Herlev Hospital
Emory University
UConn Health
The University of Texas Medical Branch, Galveston
University of Minnesota
University of Minnesota
Brigham and Women's Hospital